PART 4
Overview of Part 4
What treatments did the participants get during Part 4?
There were 47 participants in Part 4. All of them got durvalumab and
bevacizumab.
What were the results of Part 4?
The main questions the researchers wanted to answer in Part 4 were:
X What signs and symptoms did the participants have during Part 4?
The most common symptom that may or may not be caused by the
study drugs that the participants had during Part 4 was decreased
appetite.
X What medical problems happened during Part 4?
There were 70.2% of participants in Part 4 who had medical
problems that the study doctors thought might be related to the
study drugs during the study. The most common medical problem
was high levels of protein in the urine.
More details about the answers to these questions can be found later in
this summary.
34 | Clinical Study Results